Guidance Capital, Inc Bristol Myers Squibb CO Transaction History
Guidance Capital, Inc
- $272 Billion
- Q1 2024
A detailed history of Guidance Capital, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Guidance Capital, Inc holds 9,939 shares of BMY stock, worth $427,178. This represents 0.18% of its overall portfolio holdings.
Number of Shares
9,939
Previous 10,754
7.58%
Holding current value
$427,178
Previous $567 Million
15.03%
% of portfolio
0.18%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,493Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.99 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.94 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.82 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.02 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $91.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...